Sotera Health [SHC] vs Charles River [CRL] Detailed Stock Comparison
Sotera Health
NASDAQ
Loading...
Charles River
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Sotera Health wins in 9 metrics, Charles River wins in 10 metrics, with 0 ties. Charles River appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sotera Health | Charles River | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 181.89 | 681.33 | Sotera Health |
| Price-to-Book Ratio | 9.09 | 2.40 | Charles River |
| Debt-to-Equity Ratio | 460.02 | 82.04 | Charles River |
| PEG Ratio | 20.21 | -17.28 | Charles River |
| EV/EBITDA | 12.70 | 11.19 | Charles River |
| Profit Margin (TTM) | 2.14% | -1.66% | Sotera Health |
| Operating Margin (TTM) | 35.34% | 16.67% | Sotera Health |
| EBITDA Margin (TTM) | 35.34% | 16.67% | Sotera Health |
| Return on Equity | 5.14% | -1.81% | Sotera Health |
| Return on Assets (TTM) | 7.24% | 4.31% | Sotera Health |
| Free Cash Flow (TTM) | $45.09M | $501.61M | Charles River |
| 1-Year Return | 6.02% | -17.42% | Sotera Health |
| Price-to-Sales Ratio (TTM) | 4.13 | 2.00 | Charles River |
| Enterprise Value | $6.67B | $10.69B | Charles River |
| EV/Revenue Ratio | 5.93 | 2.65 | Charles River |
| Gross Profit Margin (TTM) | 56.61% | 34.59% | Sotera Health |
| Revenue per Share (TTM) | $4 | $80 | Charles River |
| Earnings per Share (Diluted) | $0.09 | $-1.31 | Sotera Health |
| Beta (Stock Volatility) | 1.81 | 1.48 | Charles River |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sotera Health vs Charles River Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sotera Health | 1.05% | -0.37% | 34.84% | 32.23% | 31.28% | 20.19% |
| Charles River | 0.06% | 0.91% | -8.48% | 18.60% | -1.21% | -10.58% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sotera Health | 6.02% | -3.25% | -34.78% | -34.78% | -34.78% | -34.78% |
| Charles River | -17.42% | -18.44% | -20.20% | 142.62% | 439.69% | 224.22% |
Performance & Financial Health Analysis: Sotera Health vs Charles River
| Metric | SHC | CRL |
|---|---|---|
| Market Information | ||
| Market Cap | $3.31B | $8.36B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,471,790 | 682,130 |
| 90 Day Avg. Volume | 1,533,057 | 964,993 |
| Last Close | $16.37 | $163.31 |
| 52 Week Range | $9.53 - $17.08 | $91.86 - $230.02 |
| % from 52W High | -4.16% | -29.00% |
| All-Time High | $30.38 (Mar 15, 2021) | $460.21 (Sep 20, 2021) |
| % from All-Time High | -46.12% | -64.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.01% |
| Quarterly Earnings Growth | -0.09% | -0.44% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.02% |
| Operating Margin (TTM) | 0.35% | 0.17% |
| Return on Equity (TTM) | 0.05% | -0.02% |
| Debt to Equity (MRQ) | 460.02 | 82.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.80 | $68.14 |
| Cash per Share (MRQ) | $1.17 | $3.72 |
| Operating Cash Flow (TTM) | $266.11M | $787.45M |
| Levered Free Cash Flow (TTM) | $218.81M | $706.38M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Sotera Health vs Charles River
| Metric | SHC | CRL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 181.89 | 681.33 |
| Forward P/E | 20.21 | 15.89 |
| PEG Ratio | 20.21 | -17.28 |
| Price to Sales (TTM) | 4.13 | 2.00 |
| Price to Book (MRQ) | 9.09 | 2.40 |
| Market Capitalization | ||
| Market Capitalization | $3.31B | $8.36B |
| Enterprise Value | $6.67B | $10.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.93 | 2.65 |
| Enterprise to EBITDA | 12.70 | 11.19 |
| Risk & Other Metrics | ||
| Beta | 1.81 | 1.48 |
| Book Value per Share (MRQ) | $1.80 | $68.14 |
Financial Statements Comparison: Sotera Health vs Charles River
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHC | CRL |
|---|---|---|
| Revenue/Sales | $254.52M | $984.17M |
| Cost of Goods Sold | $119.09M | $666.44M |
| Gross Profit | $135.43M | $317.73M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $57.04M | $74.67M |
| EBITDA | $98.09M | $184.23M |
| Pre-Tax Income | $-14.82M | $35.98M |
| Income Tax | $-1.56M | $10.10M |
| Net Income (Profit) | $-13.26M | $25.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHC | CRL |
|---|---|---|
| Cash & Equivalents | $304.39M | $229.36M |
| Total Current Assets | $554.99M | $1.51B |
| Total Current Liabilities | $225.99M | $1.05B |
| Long-Term Debt | $2.32B | $2.99B |
| Total Shareholders Equity | $414.09M | $3.24B |
| Retained Earnings | $-623.30M | $1.84B |
| Property, Plant & Equipment | $1.07B | $402.91M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHC | CRL |
|---|---|---|
| Operating Cash Flow | $58.73M | $130.09M |
| Capital Expenditures | $-19.92M | N/A |
| Free Cash Flow | $35.60M | $112.37M |
| Debt Repayment | $-3.77M | $-149.39M |
| Common Stock Repurchase | N/A | $-353.13M |
Short Interest & Institutional Ownership Analysis
| Metric | SHC | CRL |
|---|---|---|
| Shares Short | 13.75M | 3.02M |
| Short Ratio | 9.40 | 2.94 |
| Short % of Float | 0.09% | 0.07% |
| Average Daily Volume (10 Day) | 1,471,790 | 682,130 |
| Average Daily Volume (90 Day) | 1,533,057 | 964,993 |
| Shares Outstanding | 283.47M | 51.14M |
| Float Shares | 134.03M | 48.62M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 0.96% | 1.06% |
Dividend Analysis & Yield Comparison: Sotera Health vs Charles River
| Metric | SHC | CRL |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |